CYP19A1 and endometrial cancer: We have also observed that circulating estradiol and genetic variation in CYP19A1, the gene encoding aromatase, have similar effects on endometrial cancer risk (Thompson et al., 2016), suggesting that this variation mediates its effects by up-regulating CYP19A1 expression.